These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20848636)

  • 1. Multicentric castleman disease in a child with primary immunodeficiency.
    Drolet JP; Lefebvre MA; Bernard C; Mitchell D; McCusker C; Mazer B
    Pediatr Blood Cancer; 2010 Dec; 55(6):1198-200. PubMed ID: 20848636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection.
    Simonelli C; Tedeschi R; Gloghini A; Talamini R; Bortolin MT; Berretta M; Spina M; Morassut S; Vaccher E; De Paoli P; Carbone A; Tirelli U
    J Med Virol; 2009 May; 81(5):888-96. PubMed ID: 19319955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of rituximab in human immunodeficiency virus-associated multicentric Castleman disease.
    Neuville S; Agbalika F; Rabian C; Brière J; Molina JM
    Am J Hematol; 2005 Aug; 79(4):337-9. PubMed ID: 16044438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicentric Castleman disease: report of rare disease in Kuwait.
    Mohammad BA; Al-Brahim N; Kunjhibava S; Ahmad M; Ahmad M
    Gulf J Oncolog; 2009 Jul; (6):48-50. PubMed ID: 20194090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Castleman disease in an HIV-infected patient with Kaposi sarcoma.
    Saif MW
    AIDS Read; 2001 Nov; 11(11):572-6. PubMed ID: 11789020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orbital involvement in Castleman disease.
    Venizelos I; Papathomas TG; Papathanasiou M; Cheva A; Garypidou V; Coupland S
    Surv Ophthalmol; 2010; 55(3):247-55. PubMed ID: 20070998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HHV-8+, EBV+ multicentric plasmablastic microlymphoma in an HIV+ Man: the spectrum of HHV-8+ lymphoproliferative disorders expands.
    Seliem RM; Griffith RC; Harris NL; Beheshti J; Schiffman FJ; Longtine J; Kutok J; Ferry JA
    Am J Surg Pathol; 2007 Sep; 31(9):1439-45. PubMed ID: 17721201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete regression of HIV-associated multicentric Castleman disease treated with rituximab and thalidomide.
    Stary G; Kohrgruber N; Herneth AM; Gaiger A; Stingl G; Rieger A
    AIDS; 2008 Jun; 22(10):1232-4. PubMed ID: 18525273
    [No Abstract]   [Full Text] [Related]  

  • 9. Presentation of multicentric Castleman's disease with sicca syndrome, cardiomyopathy, palmar and plantar rash.
    Kingsmore SF; Silva OE; Hall BD; Sheldon EA; Cripe LD; St Clair EW
    J Rheumatol; 1993 Sep; 20(9):1588-91. PubMed ID: 8164221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy.
    van Rhee F; Stone K; Szmania S; Barlogie B; Singh Z
    Clin Adv Hematol Oncol; 2010 Jul; 8(7):486-98. PubMed ID: 20864917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial human herpesvirus-8 rash and multicentric Castleman disease.
    Wyplosz B; Carlotti A; Escaut L; Vignier N; Guettier C; Agbalika F; Vittecoq D; Dupin N
    Clin Infect Dis; 2008 Sep; 47(5):684-8. PubMed ID: 18652555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of a patient with HIV-associated multicentric Castleman disease (MCD) with thalidomide.
    Jung CP; Emmerich B; Goebel FD; Bogner JR
    Am J Hematol; 2004 Mar; 75(3):176-7. PubMed ID: 14978701
    [No Abstract]   [Full Text] [Related]  

  • 13. A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody.
    Gholam D; Vantelon JM; Al-Jijakli A; Bourhis JH
    Ann Hematol; 2003 Dec; 82(12):766-8. PubMed ID: 12898190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentric Castleman disease complicated by tumor lysis syndrome after systemic chemotherapy.
    Lee JH; Kwon KA; Lee S; Oh SY; Kwon HC; Han JY; Hong SH; Kim SH
    Leuk Res; 2010 Jan; 34(1):e42-5. PubMed ID: 19747731
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of rituximab as a salvage therapy for HIV-associated multicentric Castleman disease.
    Casquero A; Barroso A; Fernández Guerrero ML; Górgolas M
    Ann Hematol; 2006 Mar; 85(3):185-7. PubMed ID: 16341862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human herpesvirus 8 infections in patients with immunodeficiencies.
    Laurent C; Meggetto F; Brousset P
    Hum Pathol; 2008 Jul; 39(7):983-93. PubMed ID: 18570975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Hodgkin disease tumor in the neck of a patient who previously had undergone complete excision of a hyaline-vascular Castleman disease neck mass.
    Unsal Tuna EE; Ozbek C; Arda N; Ilkdogan E; Dere H; Ozdem C
    Ear Nose Throat J; 2010 Apr; 89(4):E20-3. PubMed ID: 20397132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph nodes involved by multicentric Castleman disease among HIV-positive individuals are often involved by Kaposi sarcoma.
    Naresh KN; Rice AJ; Bower M
    Am J Surg Pathol; 2008 Jul; 32(7):1006-12. PubMed ID: 18469709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicentric hyaline-vascular Castleman's disease.
    Parker MS
    Clin Radiol; 2007 Jul; 62(7):707-10. PubMed ID: 17556043
    [No Abstract]   [Full Text] [Related]  

  • 20. HIV-associated multicentric Castleman's disease.
    Stebbing J; Pantanowitz L; Dayyani F; Sullivan RJ; Bower M; Dezube BJ
    Am J Hematol; 2008 Jun; 83(6):498-503. PubMed ID: 18260115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.